<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03795064</url>
  </required_header>
  <id_info>
    <org_study_id>268/2018</org_study_id>
    <nct_id>NCT03795064</nct_id>
  </id_info>
  <brief_title>Immediate Versus Early Endovenous Ablation In Venous Ulcer</brief_title>
  <official_title>Immediate Versus Early Endovenous Ablation In Venous Ulcer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oulu University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is conducted to assess the effects of immediately started foam sclerotherapy in
      venous ulcer compared to early intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently EVRA study showed that early endovenous ablation (foam sclerotherapy and/or
      endothermal ablation) is beneficial for venous ulcer healing. This randomized controlled
      trial is conducted to assess the effects of immediate foam sclerotherapy in the first visit
      to vascular outpatient clinic (immediate intervention). Patients in control group will
      receive foam sclerotherapy at four weeks (early intervention). Endothermal ablation is
      performed in early setting in both groups when truncal vein anatomy is suitable. The primary
      outcome for this study is the reduction of venous ulcer area at four weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Venous ulcer area</measure>
    <time_frame>0 to 180 days</time_frame>
    <description>Venous ulcer area measured from calibrated digital photograph.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to ulcer healing</measure>
    <time_frame>0 to 360 days</time_frame>
    <description>Complete re-epithelialisation of ulcer area.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time of active venous ulcer</measure>
    <time_frame>0 to 360 days</time_frame>
    <description>Time from when ulcer was first time noticed to complete re-epithelialisation of ulcer area.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Venous Ulcer</condition>
  <arm_group>
    <arm_group_label>Immediate Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be treated with foam sclerotherapy immediately in the first visit to outpatient clinic (immediate intervention).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will be treated with foam sclerotherapy in the following visit to outpatient clinic at four weeks (early intervention).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Foam sclerotherapy</intervention_name>
    <description>Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.</description>
    <arm_group_label>Early Intervention</arm_group_label>
    <arm_group_label>Immediate Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endothermal ablation</intervention_name>
    <description>Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.</description>
    <arm_group_label>Early Intervention</arm_group_label>
    <arm_group_label>Immediate Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Venous ulcer &gt; 1 month

          -  Ulcer area &gt; 1cm2

          -  Palpable distal pulses / Ankle-brachial index &gt; 0,8 / Toe-brachial index &gt; 70mmhg (at
             least one criteria must be met)

        Exclusion Criteria:

          -  Leg ulcers other than venous etiology

          -  Pregnancy

          -  General contraindications for foam sclerotherapy

          -  Ulcers requiring operation theater revision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matti Pokela, Docent</last_name>
    <phone>0883152011</phone>
    <phone_ext>358</phone_ext>
    <email>matti.pokela@ppshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oulu University Hospital, Vascular Department</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Pokela, Docent</last_name>
      <phone>+35883152011</phone>
      <email>matti.pokela@ppshp.fi</email>
    </contact>
    <investigator>
      <last_name>Toni Pihlaja, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 4, 2019</study_first_submitted>
  <study_first_submitted_qc>January 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2019</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Toni Pihlaja</investigator_full_name>
    <investigator_title>Vascular Specialist</investigator_title>
  </responsible_party>
  <keyword>Venous Ulcer</keyword>
  <keyword>Venous Insufficiency of Leg</keyword>
  <keyword>Varicose Veins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

